2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses clinical trials and value-based care.
Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses how clinical trials can be changed to better align with value-based care.
Currently, there is a trend toward changing care from volume-based to value-based. Clinical trials are not value-based, what with the expenses: more testing, more evaluations, more interactions with the clinical trial team and more resources used.
To adjust for that, there are strategies that can create more value-based clinical trials. Choosing trials carefully, keeping an adequate team caring for the patient throughout the trial process, using resources efficiently, and ensuring buy-in from the entire team can help to adjust the trial system. Adjusting clinical trials currently is necessary as the reliance of value-based care becomes more acute in the future.
Related Content: